PFM Health Sciences’s Envista NVST Stock Holding History

PFM Health Sciences’s Portfolio NVST Stock Details NVST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-825,732	Closed	-$24.5M	–	73
2019 Q4	$24.5M	Buy	+825,732	New	+$23.5M	1.17%	33

Other funds holding NVST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

PFM Health Sciences's NVST Position: Q1 2020 in Review

PFM Health Sciences sold out of Envista (NVST) in Q1 2020, closing a stake of 825,732 shares — an estimated $24.5M sold.

PFM Health Sciences first reported a position in NVST in Q4 2019 and held it in 1 quarter. The position peaked at $24.5M in Q4 2019. 193 funds tracked by Wall St. Rank hold NVST as of Q1 2020.

PFM Health Sciences reported no remaining Envista position as of Q1 2020 after selling out during the quarter.
PFM Health Sciences sold 825,732 Envista shares in Q1 2020, an estimated $24.5M.
PFM Health Sciences first reported a position in Envista in Q4 2019 and held it in 1 quarter.
PFM Health Sciences's Envista position peaked at $24.5M in Q4 2019.
193 funds tracked by Wall St. Rank held Envista as of Q1 2020.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.